[{"address1": "535 W 24th Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10011", "country": "United States", "phone": "(855) 508-3568", "website": "https://www.neurogene.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York.", "fullTimeEmployees": 91, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel L. McMinn Ph.D.", "age": 50, "title": "Founder, Executive Chair & CEO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 676542, "exercisedValue": 0, "unexercisedValue": 203486}, {"maxAge": 1, "name": "Ms. Christine Mikail Cvijic J.D.", "age": 45, "title": "President, CFO & Corporate Secretary", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 623289, "exercisedValue": 0, "unexercisedValue": 658819}, {"maxAge": 1, "name": "Dr. Stuart  Cobb Ph.D.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 478807, "exercisedValue": 0, "unexercisedValue": 338906}, {"maxAge": 1, "name": "Mr. Arvind  Sreedharan", "title": "Senior Vice President of Business Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Donna M. Cochener-Metcalfe J.D.", "age": 48, "title": "Senior VP & General Counsel", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Effie  Albanis M.D.", "title": "Senior Vice President of Early Clinical & Translational Research", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew E. Mulberg CPI, FAAP, M.D.", "title": "Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ricardo  Jimenez", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1730073600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 45.15, "open": 45.08, "dayLow": 43.58, "dayHigh": 46.01, "regularMarketPreviousClose": 45.15, "regularMarketOpen": 45.08, "regularMarketDayLow": 43.58, "regularMarketDayHigh": 46.01, "forwardPE": -9.741649, "volume": 57715, "regularMarketVolume": 57715, "averageVolume": 109384, "averageVolume10days": 95680, "averageDailyVolume10Day": 95680, "bid": 43.16, "ask": 44.19, "bidSize": 100, "askSize": 100, "marketCap": 568340096, "fiftyTwoWeekLow": 12.49, "fiftyTwoWeekHigh": 55.205, "priceToSalesTrailing12Months": 614.42175, "fiftyDayAverage": 42.6325, "twoHundredDayAverage": 37.713924, "currency": "USD", "enterpriseValue": 428220640, "floatShares": 5076605, "sharesOutstanding": 12993600, "sharesShort": 934605, "sharesShortPriorMonth": 1792561, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0719, "heldPercentInsiders": 0.10694, "heldPercentInstitutions": 1.0247, "shortRatio": 6.53, "shortPercentOfFloat": 0.0805, "bookValue": 11.934, "priceToBook": 3.6651585, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": 2364000, "trailingEps": -3.67, "forwardEps": -4.49, "pegRatio": -0.43, "enterpriseToRevenue": 462.941, "enterpriseToEbitda": -6.541, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NGNE", "underlyingSymbol": "NGNE", "shortName": "Neurogene Inc.", "longName": "Neurogene Inc.", "firstTradeDateEpochUtc": 1394202600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "51d6a4c2-efb6-34ae-b4ed-f6ab994594b8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 43.74, "targetHighPrice": 65.0, "targetLowPrice": 44.0, "targetMeanPrice": 51.4, "targetMedianPrice": 49.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 153904992, "totalCashPerShare": 11.845, "ebitda": -65467000, "totalDebt": 13785000, "quickRatio": 11.822, "currentRatio": 12.174, "totalRevenue": 925000, "debtToEquity": 8.893, "revenuePerShare": 0.106, "returnOnAssets": -0.32361, "returnOnEquity": -0.41339, "freeCashflow": -34067876, "operatingCashflow": -66083000, "operatingMargins": -21.766489, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-31"}]